|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-6-9
|
|
pubmed:abstractText |
Prednisone and calcineurin inhibitors are the mainstay therapy of idiopathic nephrotic syndrome (INS) in children. However, drug dependence and toxicity associated with protracted use are common. Case series suggest that the anti-CD20 monoclonal antibody rituximab (RTX) may maintain disease remission.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1555-905X
|
|
pubmed:author |
pubmed-author:BelingheriMircoM,
pubmed-author:BenettiElisaE,
pubmed-author:DalleraNadiaN,
pubmed-author:EdefontiAlbertoA,
pubmed-author:GhiggeriGian MarcoGM,
pubmed-author:GhioLucianaL,
pubmed-author:MagnascoAlbertoA,
pubmed-author:MurerLuisaL,
pubmed-author:PasiniAndreaA,
pubmed-author:RavaniPietroP,
pubmed-author:RossiRossellaR,
pubmed-author:ScolariFrancescoF,
pubmed-author:ScozzolaFlorianaF,
pubmed-author:SicaFeliceF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1308-15
|
|
pubmed:meshHeading |
pubmed-meshheading:21566104-Adolescent,
pubmed-meshheading:21566104-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:21566104-Calcineurin,
pubmed-meshheading:21566104-Child,
pubmed-meshheading:21566104-Drug Administration Schedule,
pubmed-meshheading:21566104-Drug Therapy, Combination,
pubmed-meshheading:21566104-Enzyme Inhibitors,
pubmed-meshheading:21566104-Female,
pubmed-meshheading:21566104-Humans,
pubmed-meshheading:21566104-Immunosuppressive Agents,
pubmed-meshheading:21566104-Italy,
pubmed-meshheading:21566104-Kaplan-Meier Estimate,
pubmed-meshheading:21566104-Logistic Models,
pubmed-meshheading:21566104-Male,
pubmed-meshheading:21566104-Nephrotic Syndrome,
pubmed-meshheading:21566104-Odds Ratio,
pubmed-meshheading:21566104-Proteinuria,
pubmed-meshheading:21566104-Recurrence,
pubmed-meshheading:21566104-Remission Induction,
pubmed-meshheading:21566104-Risk Assessment,
pubmed-meshheading:21566104-Risk Factors,
pubmed-meshheading:21566104-Steroids,
pubmed-meshheading:21566104-Time Factors,
pubmed-meshheading:21566104-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.
|
|
pubmed:affiliation |
Division of Nephrology, University of Calgary, Calgary, Alberta, Canada.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
